JPH07187985A - Skin-beautifying agent consisting essentially of phytic acid or its salts - Google Patents

Skin-beautifying agent consisting essentially of phytic acid or its salts

Info

Publication number
JPH07187985A
JPH07187985A JP33523093A JP33523093A JPH07187985A JP H07187985 A JPH07187985 A JP H07187985A JP 33523093 A JP33523093 A JP 33523093A JP 33523093 A JP33523093 A JP 33523093A JP H07187985 A JPH07187985 A JP H07187985A
Authority
JP
Japan
Prior art keywords
skin
phytic acid
effect
agent
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP33523093A
Other languages
Japanese (ja)
Inventor
Kiichi Sawai
井 喜 一 澤
Takahiko Mitani
谷 隆 彦 三
Naohisa Ninomiya
宮 直 久 二
Yoshimi Tsurumi
見 善 美 鶴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Priority to JP33523093A priority Critical patent/JPH07187985A/en
Priority to EP94307020A priority patent/EP0650720A1/en
Publication of JPH07187985A publication Critical patent/JPH07187985A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:To obtain phytic acid or its salts having improving effect on keratin of skin and preventing effect on aging, useful as a skin beautifying agent. CONSTITUTION:This agent for improving keratin of skin and preventing aging comprises phytic acid or its salts. The agent is expected to prevent and treat pimple and to have suppressing effects on viruses and bacteria causing a freckle and a wart of skin.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明はフィチン酸及びその塩を
主成分とする皮膚角質改善、老化防止効果を有する美肌
剤に係る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin beautifying agent containing phytic acid and its salt as a main component and having effects of improving skin keratin and preventing aging.

【0002】[0002]

【従来技術】フィチン酸はキレート剤として古くから知
られ、食品、工業製品の添加物として利用されていた
が、最近、本出願人らにより、経口投与による尿臭、消
臭効果、代謝系疾患の治療効果等が発見され注目される
に至っている(特公平4ー76971号、特公平5ー3
9929号、米国特許4929438 号)。また、コウジ酸等
のチロシナーゼ阻害作用を利用した白色化粧料が知られ
ている(特公昭56ー18589号、特開昭63−20
8510号等)。美肌剤は、皮膚分泌物の抑制、分泌物
による異臭抑制、皮膚の保護効果、香料面からの精神学
的研究がされており、主だった薬品としては、アルコー
ル類、油脂類、香料類がデオドラント剤として、また化
粧用剤として使用されているが、これらはいずれも精神
的効果以外に有効な効果が期待できるものは少なかっ
た。 さらにまた、ニキビや皮膚に寄生する黒子、イボ
類にあっては、代謝異常、病原微生物の寄生によるもの
や、光線、毒性物質接触による組織異常によるものなど
が知られている。これらは、異常組織の手術的除去(サ
リチル酸系薬剤等にる腐蝕、液体窒素等による細胞凍結
等)、原因物質の除去、皮膚の清浄が行われる程度であ
り、有効な効果が期待できる予防、治療方法は未だ確立
されていない。
2. Description of the Related Art Phytic acid has long been known as a chelating agent and has been used as an additive for foods and industrial products. Recently, however, the present applicants have shown that urine odor, deodorizing effect, and metabolic diseases caused by oral administration. The therapeutic effects of the drug have been discovered and have attracted attention (Japanese Patent Publication No. 4-76971, Japanese Patent Publication No. 5-3).
9929, U.S. Pat. No. 4,929,438). In addition, white cosmetics utilizing the tyrosinase inhibitory action of kojic acid and the like are known (Japanese Patent Publication No. Sho 56-18589, JP-A No. 63-20).
8510, etc.). For skin beautifying agents, suppression of skin secretions, suppression of offensive odors due to secretions, skin protection effects, and psychological research from the perspective of fragrances have been conducted. It is used as a deodorant agent and a cosmetic agent, but few of them can be expected to have effective effects other than the psychological effect. In addition, acne and mollusks and warts that parasitize the skin are known to be caused by metabolic abnormalities, parasitism of pathogenic microorganisms, and tissue abnormalities caused by contact with light rays and toxic substances. These are surgical removal of abnormal tissues (corrosion caused by salicylic acid drugs, cell freezing by liquid nitrogen, etc.), removal of causative substances, and skin cleansing, and effective prevention can be expected. The treatment method has not been established yet.

【0003】[0003]

【発明が解決しようとする課題】美肌効果を期待する一
般的な製剤は、皮膚蛋白を収斂させ、汗腺をふせぎ汗が
皮膚の表面に露出するのをふせぐアルミニウム化合物等
の制汗剤、更に防臭成分として殺菌剤、酸化防止剤、香
料が使用されているが、これらは皮膚に対する毒性が強
く、その使用量も低濃度に制限され、十分満足できる効
果を得る事は難しい状況にある。また化粧石鹸等による
皮膚の清浄化は短時間の効果はあるものの長時間にわた
り清浄効果が持続する技術は報告されていない。
A general preparation that is expected to have a beautiful skin effect is an antiperspirant such as an aluminum compound that causes skin proteins to converge, blocks sweat glands, and prevents sweat from being exposed on the surface of the skin. Although bactericides, antioxidants, and fragrances are used as ingredients, these are highly toxic to the skin and the amount used is limited to a low concentration, and it is difficult to obtain a sufficiently satisfactory effect. Further, there is no report of a technique for cleaning the skin with a soap and the like for a short time, but the cleaning effect lasts for a long time.

【0004】[0004]

【課題を解決するための手段及び作用】本発明はフィチ
ン酸あるいはその塩の皮膚角質改善、老化防止効果の製
剤工夫による増強とこの物質の化粧剤、デオドラント剤
としての使用、化粧石鹸等の洗浄性物質にフィチン酸あ
るいはその塩を配合する事により、長時間にわたり清浄
効果の持続(皮膚分泌物の抑制効果)、ニキビの発生予
防、治療、皮膚寄生物によるイボ、黒子の治療、予防効
果の発見によるものであり、皮膚に対する刺激性がな
く、その体臭防止効果は顕著である美肌剤を提供するも
のである。また美肌剤の付加的効果として、米胚芽油を
添加しその効果を高め、美肌効果を有するデオドラント
剤を提供するものでもある。本発明の上記課題は、 (1)フィチン酸及びその塩からなる皮膚角質改善、老
化防止効果を有する美肌剤。 (2)1種以上の金属イオンを選択して、フィチン酸と
塩を結合させたフィチン酸活性化組成物を含有する、浴
用剤、化粧料、クリーム形態を有する美肌剤。 (3)所望により米胚芽油を配合した美肌剤より構成さ
れる。
Means and Actions for Solving the Problems The present invention is directed to improving skin keratin of phytic acid or a salt thereof, enhancing antiaging effect by devising a formulation, and using this substance as a cosmetic agent, deodorant agent, washing soap, etc. By adding phytic acid or its salt to the active substance, it has a long-lasting cleansing effect (suppressive effect on skin secretions), the prevention and treatment of acne, the treatment and prevention of warts and mollusks caused by skin parasites. The present invention is based on the discovery and provides a skin beautifying agent which is not irritating to the skin and has a remarkable body odor preventing effect. Further, as an additional effect of the skin beautifying agent, rice germ oil is added to enhance the effect, thereby providing a deodorant agent having a skin beautifying effect. The problems of the present invention are as follows: (1) A skin beautifying agent comprising phytic acid and a salt thereof which has effects of improving skin keratin and preventing aging. (2) A skin-care agent having a bath form, a cosmetic composition, or a cream form, which contains a phytic acid activating composition in which one or more metal ions are selected and phytic acid and a salt are combined. (3) It is composed of a skin beautifying agent containing rice germ oil as desired.

【0005】即ち、本発明者等は、種々検討の結果、本
発明によるフィチン酸及びその塩からなる外用性薬剤で
顕著な皮膚角質改善、老化防止によると考えられる美肌
効果を発見し、さらにまた1種以上の金属イオンを選択
して、フィチン酸と塩を形成させたフィチン酸活性化組
成物が、皮膚刺激がなく抜群の美肌効果を有する事を発
見した。
That is, as a result of various studies, the present inventors have found that the topical drug for external use consisting of phytic acid and salts thereof according to the present invention has remarkable skin keratin improvement and skin beautifying effect which is considered to be due to aging prevention. It was discovered that a phytic acid activating composition obtained by selecting one or more kinds of metal ions to form a salt with phytic acid has an outstanding skin-beautifying effect without skin irritation.

【0006】ニキビは、汗等の生体分泌物が、皮膚表面
のバクテリアにより脂肪酸等が分解され、更に酸化分解
を受けることで低級脂肪酸等の有臭物質が発生し、周辺
細胞を破壊するため、これが炎症、異臭として表れるも
のである。また、黒子、イボ類も汗等の生体分泌物によ
り皮膚表面のウイルス、バクテリアが増殖しその分泌物
や太陽光線、有毒物質により正常細胞が変異し発生する
ものである。これに対して、フィチン酸塩からなるフィ
チン酸活性化組成物はウイルス、バクテリアのウレアー
ゼ、リパーゼ、プロテアーゼ等の酵素阻害剤として作用
し、また、抗酸化剤として作用し美肌効果を発現するも
のと考えられる。
[0006] Acne is a biological secretion such as sweat, in which fatty acids and the like are decomposed by bacteria on the skin surface and further oxidatively decomposed to generate odorous substances such as lower fatty acids and destroy peripheral cells. This is manifested as inflammation and a strange odor. In addition, in mollusks and warts, viruses and bacteria on the skin surface are proliferated by biological secretions such as sweat, and normal cells are mutated by the secretions, sun rays, and toxic substances. On the other hand, a phytic acid activating composition consisting of phytate acts as an enzyme inhibitor of viruses, urease, lipase, protease, etc. of bacteria, and also acts as an antioxidant to develop a skin-beautifying effect. Conceivable.

【0007】ウレアーゼ、リパーゼ、プロテアーゼ等の
酵素阻害剤としての作用は、フィチン酸活性化組成物が
有効的なキレート剤として、バクテリアの酵素の微量金
属を取り込み、酵素を失活させることによると推定され
る。また、抗酸化剤としての作用は、フィチン酸活性化
組成物が有効的なキレート剤として、酸化の触媒となる
微量金属を封鎖することによると推定される。
The action as an enzyme inhibitor of urease, lipase, protease, etc. is presumed to be due to the fact that the phytic acid-activating composition acts as an effective chelating agent by incorporating trace metals of bacterial enzymes and deactivating the enzymes. To be done. Further, the action as an antioxidant is presumed to be due to the fact that the phytic acid activating composition serves as an effective chelating agent and sequesters a trace amount of metal serving as an oxidation catalyst.

【0008】また、フィチン酸塩は1種以上の金属イオ
ンを選択して、フィチン酸と塩を形成させたものが、生
体への作用が緩和で皮膚刺激性もない。これは、フィチ
ン酸自体の強烈なキレート効果を予めバクテリアの酵素
に必要な微量金属と置換しうる金属(Na,K,Ca,Mg等) で
フィチン酸塩としておく事で、生体への作用の緩和性と
酵素阻害剤としての作用を両立させたものと推定され
る。皮膚刺激性がない事は、デオドラント剤としては、
その長期使用、広範囲の部位への使用を考えた場合、非
常に重要なことである。
The phytate formed by selecting one or more kinds of metal ions to form a salt with phytic acid has a mild effect on the living body and has no skin irritation. This is because the strong chelating effect of phytic acid itself is replaced with a metal (Na, K, Ca, Mg, etc.) capable of substituting the trace metals required for bacterial enzymes in advance to form phytate, thereby improving the effect on the living body. It is presumed that the mildness and the action as the enzyme inhibitor are compatible with each other. The fact that there is no skin irritation is as a deodorant agent,
This is very important when considering its long-term use and wide-area use.

【0009】更に、米胚芽油の美肌効果は、非常に有効
的なものであるにも係わらず、実際には、米胚芽油自体
が酸化安定性が悪く、十分な効果が発現されにくい。こ
れに対して、フィチン酸塩からなるフィチン酸活性化組
成物は、米胚芽油の美肌効果を高める作用を発現する。
これは、製品の保存中の安定性を高める事は勿論、適用
部位での安定性又は活性によるためと推定する。
[0009] Further, although the skin-improving effect of rice germ oil is very effective, in reality, rice germ oil itself has poor oxidative stability, and it is difficult to achieve a sufficient effect. On the other hand, the phytic acid-activating composition composed of phytate exhibits an action of enhancing the skin beautiful effect of rice germ oil.
It is presumed that this is due to the stability or activity at the application site as well as the increase in the stability of the product during storage.

【0010】なお、フィチン酸塩からなるフィチン酸活
性化組成物の量は、フィチン酸として50%(W/V)以下が
好ましい。フィチン酸と塩を形成する金属は、Na,K,Ca,
Mg等が好ましく、フィチン酸と金属の添加比率は、1価
の金属はモル比でフィチン酸:金属=1:6〜1:12、
2価の金属はモル比でフィチン酸:金属=1:3〜1:
6の範囲が好ましい。以下に実施例、試験例をあげて、
本発明を更に詳細に説明する。
The amount of the phytic acid activating composition comprising phytate is preferably 50% (W / V) or less as phytic acid. The metals that form salts with phytic acid are Na, K, Ca,
Mg or the like is preferable, and the addition ratio of phytic acid and metal is such that the monovalent metal is in a molar ratio of phytic acid: metal = 1: 6 to 1:12,
The divalent metal has a molar ratio of phytic acid: metal = 1: 3 to 1:
A range of 6 is preferred. Examples and test examples are given below,
The present invention will be described in more detail.

【0011】[0011]

【実施例】【Example】

製剤例1(シャンプー) フィチン酸と水酸化マグネシウムをモル比で1:6の割
合で秤量し、適量の水を加えてフィチン酸濃度として5
%の水溶液として、フィチン酸活性化組成物Aを得た。
下記、処方に従い秤量し、常法によりシャンプーとし
た。 フィチン酸活性化組成物A 2ml アルキルエーテル硫酸ナトリウム 16g ラウリン酸ジエタノールアミド 4g プロピレングリコール 2g水 適量 合 計 100ml
Formulation Example 1 (shampoo) Phytic acid and magnesium hydroxide were weighed at a molar ratio of 1: 6, and an appropriate amount of water was added to obtain a phytic acid concentration of 5
% Phytic acid activating composition A was obtained as an aqueous solution.
The shampoo was weighed according to the following formulation and used as a shampoo by a conventional method. Phytic acid activated composition A 2 ml Sodium alkyl ether sulfate 16 g Lauric acid diethanolamide 4 g Propylene glycol 2 g Water Appropriate amount total 100 ml

【0012】製剤例2(シャンプー) フィチン酸と水酸化ナトリウムをモル比で1:6の割合
で秤量し、適量の水を加えてフィチン酸濃度として20
%の水溶液として、フィチン酸活性化組成物Bを得た。
下記、処方に従い秤量し、常法によりシャンプーとし
た。 フィチン酸活性化組成物B 25ml アミソフトCTー12 15g (ヤシイル脂肪酸セシルーLー グルタミン酸モノエタノールアミン30%) ラウリルエーテル硫酸ナトリウム 16g ヤシ油脂肪酸ジエタノールアミド 4.5g PCAソーダ(50%) 1g水 適量 合 計 100ml
Formulation Example 2 (shampoo) Phytic acid and sodium hydroxide were weighed at a molar ratio of 1: 6, and an appropriate amount of water was added to obtain a phytic acid concentration of 20.
% Phytic acid activating composition B was obtained as an aqueous solution.
The shampoo was weighed according to the following formulation and used as a shampoo by a conventional method. Phytic acid activated composition B 25 ml Amisoft CT-12 15 g (cocoylyl fatty acid cesyl-L-glutamic acid monoethanolamine 30%) Sodium lauryl ether sulfate 16 g Coconut oil fatty acid diethanolamide 4.5 g PCA soda (50%) 1 g Water proper amount total 100 ml

【0013】製剤例3(浴用剤) フィチン酸と水酸化カリウムをモル比で1:12の割合で
秤量し、適量の水を加えてフィチン酸濃度として25%
の水溶液として、フィチン酸活性化組成物Cを得た。下
記、処方に従い秤量し、定法により浴用剤とした。 フィチン酸活性化組成物C 20ml 軽質流動パラフィン 40g パルミチン酸イソプロピル 10g モノステアリン酸ソルビタン 3.5g ポリオキシエチレンステアリルエーテル 4.5g 水 適量 100ml
Formulation Example 3 (bath preparation) Phytic acid and potassium hydroxide were weighed in a molar ratio of 1:12, and an appropriate amount of water was added to obtain a phytic acid concentration of 25%.
A phytic acid-activating composition C was obtained as an aqueous solution of The following formulation was weighed and used as a bath agent by a conventional method. Phytic acid activated composition C 20 ml Light liquid paraffin 40 g Isopropyl palmitate 10 g Sorbitan monostearate 3.5 g Polyoxyethylene stearyl ether 4.5 g Water 100 ml

【0014】製剤例4(エアゾール剤) フィチン酸と水酸化ナトリウムをモル比で1:8の割合
で秤量し、適量の水を加えてフィチン酸濃度として50
%の水溶液として、フィチン酸活性化組成物Dを得た。
この溶液を噴射容器に充填しエアゾール剤とした。
Formulation Example 4 (Aerosol) Phytic acid and sodium hydroxide were weighed at a molar ratio of 1: 8, and an appropriate amount of water was added to obtain a phytic acid concentration of 50.
% Phytic acid activating composition D was obtained as an aqueous solution.
This solution was filled in a spray container to prepare an aerosol agent.

【0015】製剤例5(クリーム) フィチン酸と水酸化ナトリウムをモル比で1:8の割合
で秤量し、適量の水を加えてフィチン酸濃度として5%
の水溶液として、フィチン酸活性化組成物Eを得た。下
記、処方に従い秤量し、定法によりクリームとした。
Formulation Example 5 (Cream) Phytic acid and sodium hydroxide were weighed at a molar ratio of 1: 8, and an appropriate amount of water was added to obtain a phytic acid concentration of 5%.
A phytic acid activated composition E was obtained as an aqueous solution. The following was weighed according to the prescription and made into a cream by a conventional method.

【0016】製剤例6(洗顔料) 製剤例2記載のフィチン酸活性化組成物Bを使用して、
下記処方に従い秤量し、常法により洗顔料(フェイシャ
ルフォーム)とした。
Formulation Example 6 (Facial cleanser) Using the phytic acid-activating composition B described in Formulation Example 2,
It was weighed according to the following formulation and used as a face wash (facial foam) by a conventional method.

【0017】比較製剤1(シャンプー) 下記、処方に従い秤量し、常法によりシャンプーとし
た。 50%フィチン酸水溶液 0.2ml アルキルエーテル硫酸ナトリウム 16g ラウリン酸ジエタノールアミド 4g プロピレングリコール 2g水 適量 合 計 100ml
Comparative Preparation 1 (Shampoo) The following formulation was weighed and shampooed by a conventional method. 50% aqueous phytic acid solution 0.2 ml sodium alkyl ether sulfate 16 g lauric acid diethanolamide 4 g propylene glycol 2 g water total amount 100 ml

【0018】比較製剤2(クリーム) 下記、処方に従い秤量し、定法によりクリームとした。 ステアリン酸カリウム 7g ステアリン酸 15g グリセリン 5g水 適量 合 計 100gComparative Preparation 2 (Cream) Weighed according to the following formulation and prepared into a cream by a conventional method. Potassium stearate 7 g Stearic acid 15 g Glycerin 5 g Water Appropriate amount 100 g

【0019】比較製剤3(クリーム) 下記、処方に従い秤量し、定法によりクリームとした。 米胚芽油 1g ステアリン酸カリウム 7g ステアリン酸 15g グリセリン 5g水 適量 合 計 100gComparative Preparation 3 (Cream) Weighed according to the following formulation and prepared into a cream by a conventional method. Rice germ oil 1 g Potassium stearate 7 g Stearic acid 15 g Glycerin 5 g Water Appropriate amount total 100 g

【0020】薬効薬理試験 (皮膚角質改善、老化防止効果)5〜7週齢のヌードマ
ウスに1回あたりUVBとして0.05J/cm2 の紫
外線を5ケ月間にわたり照射し、合計照射量を4J/c
2 とした。紫外線照射終了後製剤例5のクリーム10
0〜1000μgをマウス背部10cm2 に週3回の割
合で10週間塗布した。塗布期間終了後マウスを屠殺
し、皮膚を採取した。上記のクリーム塗布部を直径1c
mの円盤にくりぬき、この円盤にシリコン(SILFL
O〜商標)を塗布し、固化させた後シリコン膜を皮膚円
盤からひきはなし、皮膚鋳型を作成した。この鋳型に低
角度から光を照射し、鋳型上に形成された皮丘、皮溝に
もとずくしわによって生ずる影の幅を0〜4に指数化し
た(Wrinkle指数)。0は全くしわが認められ
ず、4は試験でみられた最大の影の幅を示している。そ
の結果、クリームの塗布により表1に示すごとくWri
nkle指数は有意に低下しており、クリームの効果が
明らかとなった。
Pharmacological and pharmacological test (effects of improving skin keratin and preventing aging) Nude mice aged 5 to 7 weeks were irradiated with ultraviolet rays of 0.05 J / cm 2 as UVB once for 5 months, and the total irradiation dose was 4 J. / C
It was set to m 2 . Cream 10 of Preparation Example 5 after completion of UV irradiation
0 to 1000 μg was applied to 10 cm 2 of the back of the mouse 3 times a week for 10 weeks. After the application period was completed, the mouse was sacrificed and the skin was collected. Diameter of the above cream application part is 1c
hollowed out into a disk of m and silicon (SILFL
O-trademark) was applied and solidified, the silicon film was peeled off from the skin disk to prepare a skin mold. The mold was irradiated with light from a low angle, and the width of the shadow formed by the wrinkles on the cuticles and furrows formed on the mold was indexed to 0 to 4 (Wrinkle index). 0 indicates no wrinkles and 4 indicates the maximum shadow width seen in the test. As a result, by applying the cream, as shown in Table 1, Wri
The nkle index decreased significantly, demonstrating the effect of the cream.

【0021】[0021]

【表1】 [Table 1]

【0022】使用試験1 試験例1(美肌効果) 製剤例5{フィチン酸(フィチン酸として0.5%),
米胚芽油1%}、比較製剤2(フィチン酸、米胚芽油未
添加)及び比較製剤3(フィチン酸塩未添加、米胚芽油
1%)のクリームを女性被検者3人に7日間づつ試用し
てもらい、その美肌効果をアンケートにより評価した。
下記に示す様に、本発明品では美肌効果が顕著に現れ
た。
Use Test 1 Test Example 1 (Beautiful Skin Effect) Formulation Example 5 {phytic acid (0.5% as phytic acid),
Rice germ oil 1%}, comparative preparation 2 (phytic acid, rice germ oil not added) and comparative preparation 3 (phytate not added, rice germ oil 1%) cream for 3 female subjects for 7 days each We asked them to try it and evaluated the skin beautifying effect by a questionnaire.
As shown below, in the product of the present invention, the skin beautifying effect remarkably appeared.

【0023】 被験者 試用製剤 手の荒れ具合 f 比較製剤2 相変わらず、荒れた状態 f 比較製剤3 相変わらず、荒れた状態 f 製剤例5 非常に、なめらかな状態になった g 比較製剤2 相変わらず、荒れた状態 g 比較製剤3 ややなめらかな状態になった g 製剤例5 非常に、なめらかな状態になった h 比較製剤2 相変わらず、荒れた状態 h 比較製剤3 相変わらず、荒れた状態 h 製剤例5 非常に、なめらかな状態になったTest Subject Trial Preparation Condition of Hand f Comparative Formulation 2 No change, rough condition f Comparative Preparation 3 no change, rough condition f Formulation Example 5 Very smooth condition g Comparative Preparation 2 no change, rough condition g Comparative Formulation 3 slightly smoothed g Formulation Example 5 Very smoothed state h Comparative Formulation 2 as usual, rough condition h Comparative Formulation 3 still unchanged, rough condition h Formulation Example 5 Very smooth and smooth Became a state

【0024】試験例2(抗ニキビ効果) 製剤例3記載の浴用剤、製剤例5のクリーム剤、製剤例
6の洗顔料をニキビ体質のボランティア10人を対象に
配布、適時使用してもらい、下記効果についてアンケー
ト調査を行ったところ、多数のボランティアが良好以上
と回答した。また、黒子等につても聞き取り調査をした
ところ、黒子の色素が薄くなったと言う意見が多数をし
めた。
Test Example 2 (anti-acne effect) The bath agent described in Formulation Example 3, the cream preparation in Formulation Example 5, and the face cleanser in Formulation Example 6 were distributed to 10 volunteers with acne constitution and were used at appropriate times. When a questionnaire survey was conducted on the following effects, many volunteers answered that they were good or better. In addition, when conducting interviews with Kuroko and others, there were many opinions that the pigment of Kuroko had become thin.

【0025】 回答結果 強い効果あり 良好 なし(感じない) 温浴効果(暖まり感) 5 4 1 入浴後の皮膚清涼効果 4 5 1 入浴後のカユミ抑制効果 6 4 0 入浴後の皮脂分泌抑制効果 3 7 0 抗ニキビ効果 5 5 0Answer result Strong effect Good Not good (not feeling) Hot bath effect (warm feeling) 5 4 1 Skin refreshing effect after bathing 4 5 1 Itching suppression effect after bathing 6 4 0 Sebum secretion suppressing effect after bathing 3 7 0 Anti-acne effect 5 5 0

【0026】[0026]

【発明の効果】本発明によるフィチン酸及びその塩から
なる組成物を美肌剤として使用する事により、皮膚角質
改善、老化防止効果を有し、さらには皮脂の異常分泌を
抑制し、カユミの予防、皮膚清涼感(サッパリ感)、皮
膚異常組織の抑制効果を有する。ニキビ、イボ、黒子の
予防、治療のための美肌剤を提供する。
EFFECTS OF THE INVENTION By using the composition comprising phytic acid and a salt thereof according to the present invention as a skin beautifying agent, it has effects of improving skin keratin and preventing aging, and further suppressing abnormal secretion of sebum and preventing itchiness. It has the effect of suppressing skin refreshing feeling (freshness) and abnormal skin tissue. We provide skin-refining agents for the prevention and treatment of acne, warts and mollusks.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 7/50 31/66 ADA ADS ADT (72)発明者 鶴 見 善 美 名古屋市東区東外堀町35番地 株式会社三 和化学研究所内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical indication location A61K 7/50 31/66 ADA ADS ADT (72) Inventor Yoshimi Tsurumi Higashi Sotobori-cho, Higashi-ku, Nagoya-shi Address 35 Sanwa Chemical Laboratory Co., Ltd.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】フィチン酸及びその塩を主成分とする皮膚
角質改善、老化防止剤。
1. An agent for improving skin keratin and an anti-aging agent, which comprises phytic acid and a salt thereof as main components.
【請求項2】フィチン酸及びその塩を主成分とする抗ニ
キビ、イボ、黒子用美肌剤。
2. An anti-acne, wart, and skin moisturizing agent containing phytic acid and a salt thereof as a main component.
JP33523093A 1993-10-28 1993-12-28 Skin-beautifying agent consisting essentially of phytic acid or its salts Pending JPH07187985A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP33523093A JPH07187985A (en) 1993-12-28 1993-12-28 Skin-beautifying agent consisting essentially of phytic acid or its salts
EP94307020A EP0650720A1 (en) 1993-10-28 1994-09-26 Skin care and deodorant compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33523093A JPH07187985A (en) 1993-12-28 1993-12-28 Skin-beautifying agent consisting essentially of phytic acid or its salts

Publications (1)

Publication Number Publication Date
JPH07187985A true JPH07187985A (en) 1995-07-25

Family

ID=18286203

Family Applications (1)

Application Number Title Priority Date Filing Date
JP33523093A Pending JPH07187985A (en) 1993-10-28 1993-12-28 Skin-beautifying agent consisting essentially of phytic acid or its salts

Country Status (1)

Country Link
JP (1) JPH07187985A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0853336A (en) * 1994-08-11 1996-02-27 Shiseido Co Ltd Dermal agent for external use
JPH0881327A (en) * 1994-09-08 1996-03-26 Narisu Keshohin:Kk Endermic liniment for external use
JPH09309833A (en) * 1996-05-22 1997-12-02 Toyo Hakko:Kk Active oxygen-suppressing composition and its production and hypotensive medicine
US6340677B1 (en) 1997-03-11 2002-01-22 Pola Chemical Industries, Inc. Method of evaluation of skin conditioning-ameliorating agents and method of producing compositions for topical application to skin
JP2016150916A (en) * 2015-02-17 2016-08-22 株式会社マンダム Sebum secretion inhibitor

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0853336A (en) * 1994-08-11 1996-02-27 Shiseido Co Ltd Dermal agent for external use
JPH0881327A (en) * 1994-09-08 1996-03-26 Narisu Keshohin:Kk Endermic liniment for external use
JPH09309833A (en) * 1996-05-22 1997-12-02 Toyo Hakko:Kk Active oxygen-suppressing composition and its production and hypotensive medicine
US6340677B1 (en) 1997-03-11 2002-01-22 Pola Chemical Industries, Inc. Method of evaluation of skin conditioning-ameliorating agents and method of producing compositions for topical application to skin
JP3408258B2 (en) * 1997-03-11 2003-05-19 ポーラ化成工業株式会社 Method for evaluating skin condition improving agent and method for producing external preparation for skin
JP2016150916A (en) * 2015-02-17 2016-08-22 株式会社マンダム Sebum secretion inhibitor

Similar Documents

Publication Publication Date Title
US6358516B1 (en) One-step system for cleansing, conditioning, and treating the skin
EP0650720A1 (en) Skin care and deodorant compositions
MXPA97004778A (en) Formulations to reduce skin irritations and use of mis
HUT77099A (en) Formulations and methods for reducing skin irritation and use of divalent strontium cation for producing said compositions
CN110812298A (en) Antiperspirant bactericide, bromhidrosis eliminating agent containing antiperspirant bactericide and preparation method of bromhidrosis eliminating agent
JP2020519649A (en) Skin barrier composition
JP4716354B2 (en) Skin cleansing agent and skin cleansing method
US7655255B2 (en) Topical composition for transdermal administration
US5972321A (en) Acid neutralization of skin
JP2011088930A (en) Carbon dioxide percutaneous and transmucosal absorption composition
JPH05501881A (en) Derivatives of aromatic benzoates as inhibitors of esterase-producing microorganisms
JP5643872B2 (en) Carbon dioxide transdermal / mucosal absorption composition
AU2314000A (en) A cosmetic composition based on menthol and menthyl lactate, having little odor and being non-irritating
JP2003221328A (en) Skincare agent
JP3590369B2 (en) Cosmetic composition for preventing and treating acne containing cryptotanshinone
JPH07187985A (en) Skin-beautifying agent consisting essentially of phytic acid or its salts
JP5699184B2 (en) Carbon dioxide transdermal / mucosal absorption composition
JPH01502907A (en) Inhibitor of esterase-producing microorganisms, mainly for dermatology and cosmetics
JP2007262083A (en) Carbon dioxide percutaneous/transmucosal absorption composition
JP2002338426A (en) Keratin peeling promoter
WO1997027837A1 (en) New chemical mixtures with excellent microbicide, fungicide, and virucide effects; preparation methods, and use
EP4011351A1 (en) Topical cosmetic composition, use of the cosmetic composition and mask for facial application
JPH05117140A (en) Soap mixed with garlic essence containing vitamin b1
JPH07126134A (en) Deodorant agent consisting essentially of activated composition of phytic acid
JP7015064B2 (en) Keratin plug remover